Apyx Medical Corporation (APYX) posted a Q4 2025 net loss of $0.03 per share. The company generated $19.2M in revenue for the quarter. The energy technology company designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally.
Apyx Medical operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). The company serves healthcare providers with its proprietary energy-based surgical and cosmetic solutions.
A detailed analysis of Apyx Medical Corporation’s quarter follows shortly on AlphaStreet.
This article was generated using AlphaStreet’s proprietary financial analysis technology and reviewed by our editorial team.
The post Apyx Medical Corporation (APYX) Reports Q4 Earnings first appeared on Alphastreet.
